The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; Sanofi; SERVIER; Takeda; TG Therapeutics; Verastem
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Celltrion; EUSA Pharma; Gilead Sciences; Immune Design; Janssen-Cilag; Kyowa Hakko Kirin; MSD; Portola Pharmaceuticals; Roche; Sandoz; SERVIER; Verastem
Phase 3 trial (GCT3013-05) of epcoritamab versus standard of care in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
 
Catherine Thieblemont
Honoraria - Celgene; Gilead Sciences; Janssen; Novartis; Roche
Consulting or Advisory Role - Celgene; Janssen; Novartis; Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Gilead Sciences; Janssen; Novartis; Roche
 
Michael Roost Clausen
Consulting or Advisory Role - Abbvie; Gilead Sciences; Janssen
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences
 
Anna Sureda Balari
Honoraria - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Janssen-Cilag; Merck Sharp & Dohme; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Novartis; Takeda
Speakers' Bureau - Takeda
Other Relationship - Celgene; Gilead Sciences; Roche; Sanofi; Takeda
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Christopher Fox
Honoraria - Abbvie; AstraZeneca; Atara Biotherapeutics; Celgene/Bristol-Myers Squibb; Genmab; Gilead Sciences; Incyte; MorphoSys; Roche; Takeda
 
Su Young Kim
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Signe Diness Vindeloev
Employment - Genmab
Stock and Other Ownership Interests - Genmab
 
Pieternella Lugtenburg
Consulting or Advisory Role - Celgene; Genmab; Roche/Genentech; SERVIER; Takeda
Research Funding - SERVIER (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Celgene